Project Title: A Phase III, Multicenter, Randomized, Double-Blind, Placebo- Controlled Study to Evaluate the Efficacy, Immunogenicity and Safety of Single dose of Dengue Tetravalent Vaccine, Live Attenuated (Recombinant, Lyophilized) – “DengiAll” of Panacea Biotec Limited in Healthy Indian Adults
Year: 2024- Ongoing
